Teva Asks Fed. Circ. To Nix Lilly's Chemo Patent Win
A Teva subsidiary urged the Federal Circuit to toss a ruling that the company's label for a proposed chemotherapy drug generic infringes an Eli Lilly patent, saying Wednesday that the label...To view the full article, register now.
Already a subscriber? Click here to view full article